Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
3
×
boston blog main
boston top stories
clinical trials
indiana blog main
investing
3
×
life sciences
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
3
×
venture capital
3
×
boulder/denver blog main
boulder/denver top stories
cancer
cell therapy
deals
detroit blog main
detroit top stories
diabetes
fda
indiana top stories
national
national top stories
new york top stories
raleigh-durham top stories
roche
san diego top stories
san francisco top stories
seattle top stories
spark therapeutics
startups
texas blog main
texas top stories
type 1 diabetes
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
What
bio
patients
roundup
advantages
ahead
asco
bar
beta
bionics
blood
branded
brings
choices
closed
commissioner
consumers
costly
counterweight
developing
device
diabetes
driven
drug
drugs
elevatebio
expect
fda
gamble
generic
graft
heads
key
levels
manages
market
medco’s
medical
medications
million
monitors
Language
unset
Current search:
investing
×
photo
×
" venture capital "
×
biotech
×
" seattle blog main "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
